Undervalued NASDAQ Stocks Poised for Growth – $I
Post# of 99123
(Total Views: 126)
Posted On: 06/29/2023 9:18:01 AM
Undervalued NASDAQ Stocks Poised for Growth – $INBS, $IPA, $RMED, $KAVL
https://thestreetreports.com/undervalued-nasd...rmed-kavl/
The ultimate aim of any investors is to find value in the market so that they can make significant profits in the long term. There are many stocks in the market that may be undervalued since the wider market may not have realized the potential of those companies. Hence, those stocks present a major opportunity to investors. Here is a quick look at some NASDAQ-listed undervalued stocks that could be on the verge of growth.
Intelligent Bio Solutions Inc (NASDAQ: INBS) – The medical technology company is involved in the delivery of intelligent non-invasive and fast-testing solutions. It was in the news on June 28 after it announced that it had received guidance from the United States Food and Drug Administration about the regulatory classification of its Intelligent Fingerprinting Drug Screening Cartridge.
The agency had provisionally decided that the product fell into the 21 CFR 862.3650, Opiate Test System, which made it a Class II device that necessitated the pre-market notification of 501 (K) and clearance from the FDA before marketing.
ImmunoPrecise Antibodies Ltd (NASDAQ: IPA) – On June 13 the company was in the news after it announced that a new use case had been discovered for the Information Integration Dilemma (IID) solution that had been developed by BioStrand, its subsidiary unit.
The IID had been a problem for both researchers and investors for a long time since there were considerable complexities with regard to the integration of a variety of data types. However, the LENS platform from BioStrand and HYFT technology had been successful in addressing the problem. It was a major new development for ImmunoPrecise Antibodies Ltd.
Ra Medical Systems Inc (NASDAQ: RMED) – The company announced on June 28 that its subsidiary Catheter Precision had submitted the data necessary for determining the CE marking of its LockeT product to the European Notified Body. David Jenkins, the interim Chief Executive Officer, noted that it was a significant development for the company.
He went on to note that everyone at the company was excited about the prospects of the product not only in the United States but also at an international level. The CE Mark is expected in the third quarter and then the European market would be open.
Kaival Brands Innovations Group Inc (NASDAQ: KAVL) – The company, which is the distributor of all BIDI Vapor LLC products in the United States, made a key announcement on June 15. It announced that it had made the initial shipment of BIDI Sticks to more than 900 Mapco and Kwik Trip outlets.
Kaival Brands Innovations Group Inc hopes to take that number to 1200 in 2023, with 900 Kwik Trip locations included in that number.
https://thestreetreports.com/undervalued-nasd...rmed-kavl/
The ultimate aim of any investors is to find value in the market so that they can make significant profits in the long term. There are many stocks in the market that may be undervalued since the wider market may not have realized the potential of those companies. Hence, those stocks present a major opportunity to investors. Here is a quick look at some NASDAQ-listed undervalued stocks that could be on the verge of growth.
Intelligent Bio Solutions Inc (NASDAQ: INBS) – The medical technology company is involved in the delivery of intelligent non-invasive and fast-testing solutions. It was in the news on June 28 after it announced that it had received guidance from the United States Food and Drug Administration about the regulatory classification of its Intelligent Fingerprinting Drug Screening Cartridge.
The agency had provisionally decided that the product fell into the 21 CFR 862.3650, Opiate Test System, which made it a Class II device that necessitated the pre-market notification of 501 (K) and clearance from the FDA before marketing.
ImmunoPrecise Antibodies Ltd (NASDAQ: IPA) – On June 13 the company was in the news after it announced that a new use case had been discovered for the Information Integration Dilemma (IID) solution that had been developed by BioStrand, its subsidiary unit.
The IID had been a problem for both researchers and investors for a long time since there were considerable complexities with regard to the integration of a variety of data types. However, the LENS platform from BioStrand and HYFT technology had been successful in addressing the problem. It was a major new development for ImmunoPrecise Antibodies Ltd.
Ra Medical Systems Inc (NASDAQ: RMED) – The company announced on June 28 that its subsidiary Catheter Precision had submitted the data necessary for determining the CE marking of its LockeT product to the European Notified Body. David Jenkins, the interim Chief Executive Officer, noted that it was a significant development for the company.
He went on to note that everyone at the company was excited about the prospects of the product not only in the United States but also at an international level. The CE Mark is expected in the third quarter and then the European market would be open.
Kaival Brands Innovations Group Inc (NASDAQ: KAVL) – The company, which is the distributor of all BIDI Vapor LLC products in the United States, made a key announcement on June 15. It announced that it had made the initial shipment of BIDI Sticks to more than 900 Mapco and Kwik Trip outlets.
Kaival Brands Innovations Group Inc hopes to take that number to 1200 in 2023, with 900 Kwik Trip locations included in that number.
(0)
(0)